These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30531465)

  • 41. The Biology of Sex and Sport.
    Bassett AJ; Ahlmen A; Rosendorf JM; Romeo AA; Erickson BJ; Bishop ME
    JBJS Rev; 2020 Mar; 8(3):e0140. PubMed ID: 32224635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A question of 'fairness': Why ethics should factor in the Court of Arbitration for Sport's decision on the IAAF Hyperandrogenism Regulations.
    Camporesi S
    Br J Sports Med; 2019 Jul; 53(13):797-798. PubMed ID: 29643090
    [No Abstract]   [Full Text] [Related]  

  • 43. Sport and Transgender People: A Systematic Review of the Literature Relating to Sport Participation and Competitive Sport Policies.
    Jones BA; Arcelus J; Bouman WP; Haycraft E
    Sports Med; 2017 Apr; 47(4):701-716. PubMed ID: 27699698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards a Determination of the Physiological Characteristics Distinguishing Successful Mixed Martial Arts Athletes: A Systematic Review of Combat Sport Literature.
    James LP; Haff GG; Kelly VG; Beckman EM
    Sports Med; 2016 Oct; 46(10):1525-51. PubMed ID: 26993133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outstanding performances during elite-standard short and middle-distance finals and the hyperandrogenism regulation-A detailed analysis of Caster Semenya's results.
    Ospina-Betancurt J; Zakynthinaki MS
    J Sports Sci; 2020 Mar; 38(6):703-709. PubMed ID: 32050847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doping in Two Elite Athletics Competitions Assessed by Randomized-Response Surveys.
    Ulrich R; Pope HG; Cléret L; Petróczi A; Nepusz T; Schaffer J; Kanayama G; Comstock RD; Simon P
    Sports Med; 2018 Jan; 48(1):211-219. PubMed ID: 28849386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hurdling over sex? Sport, science, and equity.
    Ha NQ; Dworkin SL; Martínez-Patiño MJ; Rogol AD; Rosario V; Sánchez FJ; Wrynn A; Vilain E
    Arch Sex Behav; 2014 Aug; 43(6):1035-42. PubMed ID: 25085349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Worldwide distribution of blood values in elite track and field athletes: Biomarkers of altered erythropoiesis.
    Robinson N; Saugy J; Schütz F; Faiss R; Baume N; Giraud S; Saugy M
    Drug Test Anal; 2019 Apr; 11(4):567-577. PubMed ID: 30345707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Why are there no platypuses at the Olympics?: A teleological case for athletes with disorders of sexual development to compete within their sex category.
    Gamble N; Pruski M
    S Afr J Sports Med; 2020; 32(1):v32i1a7918. PubMed ID: 36818986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of drugs and nutritional supplements in top-level track and field athletes.
    Tscholl P; Alonso JM; Dollé G; Junge A; Dvorak J
    Am J Sports Med; 2010 Jan; 38(1):133-40. PubMed ID: 19812387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changing identity through sport: The Paralympic sport club experience among adolescents with mobility impairments.
    Piatt J; Kang S; Wells MS; Nagata S; Hoffman J; Taylor J
    Disabil Health J; 2018 Apr; 11(2):262-266. PubMed ID: 29107585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why do endocrine profiles in elite athletes differ between sports?
    Sönksen PH; Holt RIG; Böhning W; Guha N; Cowan DA; Bartlett C; Böhning D
    Clin Diabetes Endocrinol; 2018; 4():3. PubMed ID: 29445518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health promotion by International Olympic Sport Federations: priorities and barriers.
    Mountjoy M; Junge A; Budgett R; Doerr D; Leglise M; Miller S; Moran J; Foster J
    Br J Sports Med; 2019 Sep; 53(17):1117-1125. PubMed ID: 30877137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing for boosting at the Paralympic games: policies, results and future directions.
    Blauwet CA; Benjamin-Laing H; Stomphorst J; Van de Vliet P; Pit-Grosheide P; Willick SE
    Br J Sports Med; 2013 Sep; 47(13):832-7. PubMed ID: 23681503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The construction of categories in sport: Unfair advantages, equality of opportunity and strict attainability.
    Camporesi S; Hämäläinen M
    Eur J Sport Sci; 2021 Nov; 21(11):1492-1499. PubMed ID: 34120575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Not Available].
    Bieri A; Kamber M; Sterchi M; Mullis PE
    Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender verification testing in sport.
    Ferris EA
    Br Med Bull; 1992 Jul; 48(3):683-97. PubMed ID: 1450892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender transports: privileging the "natural" in gender testing debates for intersex and transgender athletes.
    Wahlert L; Fiester A
    Am J Bioeth; 2012; 12(7):19-21. PubMed ID: 22694025
    [No Abstract]   [Full Text] [Related]  

  • 59. Women with hyperandrogenism in elite sports: scientific and ethical rationales for regulating.
    Bermon S; Vilain E; Fénichel P; Ritzén M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):828-30. PubMed ID: 25587809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caster Semenya: sport, categories and the creative role of ethics.
    Camporesi S; Maugeri P
    J Med Ethics; 2010 Jun; 36(6):378-9. PubMed ID: 20530091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.